|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.40 USD | -2.78% |
|
-11.98% | -9.85% |
| 08/05 | Sarepta Therapeutics' Commercial Portfolio Alone Should Support Higher Valuation, Wedbush Says | MT |
| 07/05 | Sarepta Therapeutics, Inc., Q1 2026 Earnings Call, May 06, 2026 |
MarketScreener Strategies
Search
No results for this search
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition